In line with the observed dependence on CD8+ T-cells, tumour growth delay was abrogated when lymphocyte egress was inhibited by the application of FTY720, leading to bigger tumours in infected mice compared to untreated infected tumour-bearing mice (Fig 6D). This evidence concerns the gene CD8A and neoplasm.